Captopril mitigates splenomegaly and myelofibrosis in the Gata1 (low) murine model of myelofibrosis

Allogeneic stem cell transplantation is currently the only curative therapy for primary myelofibrosis (MF), while the JAK2 inhibitor, ruxolitinib. Has been approved only for palliation. Other therapies are desperately needed to reverse life‐threatening MF. However, the cell(s) and cytokine(s) that p...

Descripción completa

Detalles Bibliográficos
Autores principales: Corey, Seth J., Jha, Jyoti, McCart, Elizabeth A., Rittase, William B., George, Jeffy, Mattapallil, Joseph J., Mehta, Hrishikesh, Ognoon, Mungunsukh, Bylicky, Michelle A., Summers, Thomas A., Day, Regina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111823/
https://www.ncbi.nlm.nih.gov/pubmed/29971909
http://dx.doi.org/10.1111/jcmm.13710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111823/
https://www.ncbi.nlm.nih.gov/pubmed/29971909
http://dx.doi.org/10.1111/jcmm.13710

Ejemplares similares